Grünwald, V., & Merseburger, A. S. (2012). Axitinib for the treatment of patients with advanced metastatic renal cell carcinoma (mRCC) after failure of prior systemic treatment. Dove Medical Press.
Citação norma ChicagoGrünwald, Viktor, and Axel S. Merseburger. Axitinib for the Treatment of Patients With Advanced Metastatic Renal Cell Carcinoma (mRCC) After Failure of Prior Systemic Treatment. Dove Medical Press, 2012.
Deismireacht MLAGrünwald, Viktor, and Axel S. Merseburger. Axitinib for the Treatment of Patients With Advanced Metastatic Renal Cell Carcinoma (mRCC) After Failure of Prior Systemic Treatment. Dove Medical Press, 2012.
Rabhadh: D'fhéadfadh nach mbeadh na deismireachtaí seo 100% cruinn i gcónaí.